|
NFX1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.441600E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.034400E-02 |
| Normal-vs-Stage2 |
2.169600E-02 |
| Normal-vs-Stage3 |
1.551160E-01 |
| Normal-vs-Stage4 |
4.055200E-01 |
| Stage1-vs-Stage2 |
5.351000E-01 |
| Stage1-vs-Stage3 |
8.804000E-01 |
| Stage1-vs-Stage4 |
9.587800E-01 |
| Stage2-vs-Stage3 |
7.851000E-01 |
| Stage2-vs-Stage4 |
8.290600E-01 |
| Stage3-vs-Stage4 |
9.674800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.820200E-02 |
| Normal-vs-AfricanAmerican |
1.833800E-01 |
| Normal-vs-Asian |
1.469850E-02 |
| Caucasian-vs-AfricanAmerican |
6.211400E-01 |
| Caucasian-vs-Asian |
3.760400E-01 |
| AfricanAmerican-vs-Asian |
2.076200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.781900E-02 |
| Normal-vs-Female |
2.320400E-01 |
| Male-vs-Female |
6.460000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.729700E-02 |
| Normal-vs-Extreme_Weight |
1.476420E-02 |
| Normal-vs-Obese |
8.397400E-01 |
| Normal-vs-Extreme_Obese |
1.180260E-02 |
| Normal_Weight-vs-Extreme_Weight |
6.818000E-01 |
| Normal_Weight-vs-Obese |
2.262600E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.777800E-01 |
| Extreme_Weight-vs-Obese |
6.870000E-02 |
| Extreme_Weight-vs-Extreme_Obese |
5.425000E-01 |
| Obese-vs-Extreme_Obese |
1.652180E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.691200E-01 |
| Normal-vs-Age(41-60Yrs) |
5.324200E-01 |
| Normal-vs-Age(61-80Yrs) |
3.955400E-03 |
| Normal-vs-Age(81-100Yrs) |
1.355200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.933600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.535810E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.723800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.844130E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.938410E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.058800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
6.651800E-02 |
| Normal-VS-Type2 PRCC |
3.210100E-02 |
| Normal-VS-KIRP CIMP |
9.771000E-01 |
| Normal-VS-Unclassified PRCC |
2.297600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.731400E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.228600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.475200E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.309000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.269400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
5.253600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.841970E-03 |
| Normal-vs-N1 |
3.004600E-01 |
| Normal-vs-N2 |
2.140000E-03 |
| N0-vs-N1 |
4.039400E-01 |
| N0-vs-N2 |
4.979400E-03 |
| N1-vs-N2 |
1.741520E-02 |
|
|
